Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Staten Island, New York 10305


The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.

Study summary:

A cross-sectional of "aspirin resistance in hemodialysis patients" previously done in our institution showed that 23/66 (34.7%) hemodialysis patients were aspirin resistant. In a recent systematic review, renal impairment was associated with aspirin resistance . This association was seen in only two out of the twenty studies used in this meta-analysis . Both these studies are from the same center with a predominant Asian population. In this study we will try to evaluate the prevalence of aspirin resistance in CKD patient without being limited to a specific ethnicity.


Inclusion Criteria: - Patients with known structural kidney disease as evident by history or by urinalysis and CKD stage III or IV determined by MDRD formula and who are taking aspirin. Exclusion Criteria: - Younger than 18 years of age. - Bleeding disorder or myeloproliferative disorders. - Thrombocytopenia with platelets < 100.000. - Malignancy. - Acute hemorrhagic disease. - A recent history of receipt of platelet glycoprotein IIb/IIIa blockers. - Liver disease as evident by abnormal liver function and total bilirubin > 2mg/dl. - use of anticoagulation.



Primary Contact:

Principal Investigator
Suzanne El_Sayegh, MD
Staten Island University Hospital

Backup Contact:


Location Contact:

Staten Island, New York 10305
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.